These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23479983)

  • 1. [Quality of life in patients with coronary heart disease associated with metabolic syndrome: results of factor analysis].
    Kaliuzhin VV; Tepliakov AT; Riazantseva NV; Bespalova ID; Kamaev DIu; Kaliuzhina EV
    Ter Arkh; 2012; 84(12):18-22. PubMed ID: 23479983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quality of life in patients with risk factors of coronary heart disease].
    Kwaśniewska M; Drygas W
    Przegl Lek; 2005; 62(9):863-70. PubMed ID: 16541719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The course of coronary heart disease and quality of life in patients with anxiety of different degree].
    Ibatov AD
    Ter Arkh; 2007; 79(12):35-8. PubMed ID: 18220028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of symptoms and depressive mood among working-aged coronary heart disease patients.
    Sumanen MP; Suominen SB; Koskenvuo MJ; Sillanmäki LH; Mattila KJ
    Health Qual Life Outcomes; 2004 Nov; 2():60. PubMed ID: 15533254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome is a risk factor for development of heart failure in acute myocardial infarction.
    Bari MA; Islam MS; Paul GK; Chanda SK; Siddique SR; Khan TA
    Mymensingh Med J; 2012 Oct; 21(4):633-8. PubMed ID: 23134910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome].
    Kalyuzhin VV; Teplyakov AT; Pushnikova EY; Bespalova LD; Kalyuzhina EV; Kolesnikov RN
    Ter Arkh; 2013; 85(5):68-72. PubMed ID: 23819342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Deformation, rotation, and axial torsion of the left ventricle in coronary heart disease patients with its severe dysfunction].
    Pavliukova EN; Karpov RS
    Ter Arkh; 2012; 84(9):11-6. PubMed ID: 23091847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological distress mediates the effects of socio-demographic and clinical characteristics on the physical health component of health-related quality of life in patients with coronary heart disease.
    Lee DT; Choi KC; Chair SY; Yu DS; Lau ST
    Eur J Prev Cardiol; 2014 Jan; 21(1):107-16. PubMed ID: 22679250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal medical treatment of cardiovascular risk factors: can we prevent the development of heart failure?
    Alba AC; Delgado DH
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):147-57. PubMed ID: 19210211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus].
    Tepliakov AT; Maianskaia SD; Bolotskaia LA; Vdovina TV; Stepacheva TA; Kuznetsova AV; Lukinov AV; Derbeneva NV; Frants MV; Shilov SN
    Ter Arkh; 2009; 81(3):62-9. PubMed ID: 19459427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation and validation of two Chinese health-related quality of life instruments in patients with coronary heart disease.
    Thompson DR; Oldridge NB; Yu DS; Yu CM
    Hong Kong Med J; 2009 Feb; 15 Suppl 2():8-11. PubMed ID: 19258626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is type-D a stable construct? An examination of type-D personality in patients before and after cardiac surgery.
    Dannemann S; Matschke K; Einsle F; Smucker MR; Zimmermann K; Joraschky P; Weidner K; Köllner V
    J Psychosom Res; 2010 Aug; 69(2):101-9. PubMed ID: 20624508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus).
    Carlson LE; Bultz BD; Morris DG
    Health Qual Life Outcomes; 2005 Jan; 3():7. PubMed ID: 15676074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A course of coronary heart disease and quality of life in patients with varying depressive states].
    Ibatov AD; Syrkin AL; Veĭn AM; Syrkina EA; Sulimov VA; Lomakin VV
    Ter Arkh; 2004; 76(8):25-8. PubMed ID: 15471391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation of the MacNew quality of life questionnaire after myocardial infarction in an Iranian population.
    Asadi-Lari M; Javadi HR; Melville M; Oldridge NB; Gray D
    Health Qual Life Outcomes; 2003 Jul; 1():23. PubMed ID: 12869205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of type D personality in predicting five-year cardiac events above and beyond concurrent symptoms of stress in patients with coronary heart disease.
    Denollet J; Pedersen SS; Vrints CJ; Conraads VM
    Am J Cardiol; 2006 Apr; 97(7):970-3. PubMed ID: 16563897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procollagen III N-terminal peptide predicts short-term prognosis and cardiac remodeling in coronary heart disease patients with metabolic syndrome.
    Deng W; Chen QW; Li GQ; Li XS; Ke DZ; Mo XG; Wang L; Wang P; Wu ZQ
    Am J Med Sci; 2011 Jan; 341(1):10-6. PubMed ID: 21139493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Level of anxiety and self-image in patients with coronary heart disease].
    Pawłowskal B; Papuć E; Opolska A; Witczak W
    Psychiatr Pol; 2006; 40(6):1069-79. PubMed ID: 17444288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sociodemographic, disease status, and illness perceptions predictors of global self-ratings of health and quality of life among those with coronary heart disease--one year follow-up study.
    Aalto AM; Aro AR; Weinman J; Heijmans M; Manderbacka K; Elovainio M
    Qual Life Res; 2006 Oct; 15(8):1307-22. PubMed ID: 16826444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome.
    Corsetti JP; Zareba W; Moss AJ; Sparks CE
    Atherosclerosis; 2004 Dec; 177(2):367-73. PubMed ID: 15530912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.